Horizon Financial Services’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,005
| Closed | -$22.2K | – | 51 |
|
|
2023
Q1 | $22.2K | Hold |
12,005
| – | – | 0.02% | 51 |
|
|
2022
Q4 | $13.3K | Hold |
12,005
| – | – | 0.01% | 52 |
|
|
2022
Q3 | $28K | Hold |
12,005
| – | – | 0.02% | 58 |
|
|
2022
Q2 | $36K | Hold |
12,005
| – | – | 0.03% | 55 |
|
|
2022
Q1 | $82K | Hold |
12,005
| – | – | 0.05% | 56 |
|
|
2021
Q4 | $100K | Hold |
12,005
| – | – | 0.06% | 65 |
|
|
2021
Q3 | $89K | Hold |
12,005
| – | – | 0.06% | 76 |
|
|
2021
Q2 | $82K | Hold |
12,005
| – | – | 0.06% | 67 |
|
|
2021
Q1 | $123K | Hold |
12,005
| – | – | 0.11% | 27 |
|
|
2020
Q4 | $84K | Hold |
12,005
| – | – | 0.08% | 31 |
|
|
2020
Q3 | $98K | Buy |
+12,005
| New | +$98K | 0.1% | 27 |
|